Episode #14 - These hamsters have birthed billions for biotech
Aug 3, 2016 - 00:20:43
Radio and PodcastLive Radio & PodcastsLoading episode
Fetching episode details...
Radio and PodcastLive Radio & PodcastsRadio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & Podcasts
An FDA panel reviewed a drug for Duchenne muscular dystrophy called drisaperson on Tuesday. What it found is not encouraging. The Signal podcast takes a look at what happened and where things go from here.
UPDATE: What happened at the FDA panel review of one Duchenne drug? is an episode from Signal by Signal. An FDA panel reviewed a drug for Duchenne muscular dystrophy called drisaperson on Tuesday. What it found is not encouraging. The Signa...
This episode belongs to Signal.
Use the player on this page to stream the episode online.
Published Nov 25, 2015, 00:08:23 long, audio available.
Continue listening to more episodes from Signal.
Aug 3, 2016 - 00:20:43
Jul 13, 2016 - 00:24:46
Jun 15, 2016 - 00:25:37
May 4, 2016 - 00:23:04
Apr 18, 2016 - 00:23:09
Feb 11, 2016 - 00:03:07
Jan 28, 2016 - 00:20:12